Search results

Meeting of minds about potential next-generation cancer treatment for Australians

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

Lutetium-177 used for advanced prostate cancer

Accelerator Mass Spectrometry (AMS) is an ultra-sensitive analytical technique based on the use of an ion accelerator as a powerful mass spectrometer.

The BRIGHT Nanoprobe beamline provides a unique facility capable of spectroscopic and full-field imaging. NANO will undertake high-resolution elemental mapping and ptychographic coherent diffraction imaging. Elemental mapping and XANES studies (after DCM upgrade) will be possible at sub-100 nm resolution, with structural features able to be studied down to 15 nm using ptychography.

This COVIDSafe Plan describes the actions that ANSTO will take to keep our staff, contractors and visitors safe and minimise the risk of the spread of COVID-19 infection.

ANSTO’s user office in Melbourne offers access to the Australian Synchrotron, a world-class research facility with over 4,000 user visits per year. ANSTO seeks collaboration and partnerships with research organisations, scientific users and commercial users.

The OPAL research reactor's design and integrated safety features mean it is extremely safe; a fact confirmed by independent analysis.

This statement outlines the ways in which the events organised and run by ANSTO meet the goals outlined in the ANSTO Environmental Sustainability Strategy in the aim to reduce ANSTO’s environmental footprint.  

Highlighting the contribution of four inspirational ANSTO leaders on International Women's Day.

Radiocarbon measurements at ANSTO’s Centre for Accelerator Science have supported research published that provided insights into what the environment was like for the Aboriginal artists who created rock art over intervals spanning 43,000 years.

Research to determine the potential dose from long- lived radioactive substances at mining, legacy sites and nuclear facilities.

Robert Russell has been awarded his PhD